CN1056369C - 哒嗪酮衍生物或其盐和制备方法 - Google Patents

哒嗪酮衍生物或其盐和制备方法 Download PDF

Info

Publication number
CN1056369C
CN1056369C CN94193266A CN94193266A CN1056369C CN 1056369 C CN1056369 C CN 1056369C CN 94193266 A CN94193266 A CN 94193266A CN 94193266 A CN94193266 A CN 94193266A CN 1056369 C CN1056369 C CN 1056369C
Authority
CN
China
Prior art keywords
alkyl
group
hydrogen atom
compound
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94193266A
Other languages
English (en)
Chinese (zh)
Other versions
CN1130378A (zh
Inventor
重原格
小田原新二
冈田宏
木村博彦
尾松正人
中山仁志
樋口理惠
武南多纪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Publication of CN1130378A publication Critical patent/CN1130378A/zh
Application granted granted Critical
Publication of CN1056369C publication Critical patent/CN1056369C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN94193266A 1993-09-06 1994-08-22 哒嗪酮衍生物或其盐和制备方法 Expired - Fee Related CN1056369C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP24634493 1993-09-06
JP246344/1993 1993-09-06
JP246344/93 1993-09-06
JP87999/1994 1994-04-01
JP8799994 1994-04-01
JP87999/94 1994-04-01

Publications (2)

Publication Number Publication Date
CN1130378A CN1130378A (zh) 1996-09-04
CN1056369C true CN1056369C (zh) 2000-09-13

Family

ID=26429218

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94193266A Expired - Fee Related CN1056369C (zh) 1993-09-06 1994-08-22 哒嗪酮衍生物或其盐和制备方法

Country Status (12)

Country Link
US (1) US5763439A (cg-RX-API-DMAC10.html)
EP (1) EP0717734B1 (cg-RX-API-DMAC10.html)
KR (1) KR960704853A (cg-RX-API-DMAC10.html)
CN (1) CN1056369C (cg-RX-API-DMAC10.html)
AT (1) ATE173471T1 (cg-RX-API-DMAC10.html)
AU (1) AU681694B2 (cg-RX-API-DMAC10.html)
CA (1) CA2170637C (cg-RX-API-DMAC10.html)
DE (1) DE69414716T2 (cg-RX-API-DMAC10.html)
ES (1) ES2125474T3 (cg-RX-API-DMAC10.html)
IL (1) IL110845A (cg-RX-API-DMAC10.html)
TW (1) TW259787B (cg-RX-API-DMAC10.html)
WO (1) WO1995007264A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE192741T1 (de) * 1994-01-25 2000-05-15 Nissan Chemical Ind Ltd Pyridazinon-derivate
AU756275B2 (en) * 1998-08-14 2003-01-09 Nihon Nohyaku Co., Ltd. Pyridazinone derivatives
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
CN102532126B (zh) * 2012-02-10 2014-06-18 贵州大学 2-取代-4-氯-5-[5-取代胺基-2-(1,3,4-噻二唑基)-巯基]-3(2h)-哒嗪酮类衍生物及其制备方法和用途
CN104230902B (zh) * 2013-06-19 2017-05-10 中国科学院大连化学物理研究所 一类6,7‑二羟基香豆素衍生物、制备方法和应用
US20220162169A1 (en) * 2019-02-20 2022-05-26 Jiangsu Hengrui Medicine Co., Ltd. 6-oxo-1,6-dihydropyridazine prodrug derivative, preparation method therefor, and application thereof in medicine
WO2023166067A1 (en) 2022-03-02 2023-09-07 Syngenta Crop Protection Ag Microbiocidal pyridazinone amide derivatives
WO2024132895A1 (en) 2022-12-19 2024-06-27 Syngenta Crop Protection Ag Microbiocidal dihydrooxadiazinyl pyridazinone compounds
CN120379969A (zh) 2022-12-19 2025-07-25 先正达农作物保护股份公司 杀微生物的哒嗪二氢噁二嗪衍生物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186817A1 (en) * 1984-12-10 1986-07-09 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it
EP0275997A1 (en) * 1987-01-20 1988-07-27 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, process for its preparation and antagonistic agent against SRS-A containing it
EP0376079A1 (en) * 1988-12-20 1990-07-04 Nissan Chemical Industries Ltd. 3(2H)pyridazinones, processes for their preparation and antagonistic agent against SRS-A
WO1990013292A1 (en) * 1989-04-28 1990-11-15 Brigham And Women's Hospital Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
EP0482208A1 (en) * 1990-04-25 1992-04-29 Nissan Chemical Industries Ltd. Pyridazinone derivative

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186817A1 (en) * 1984-12-10 1986-07-09 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it
EP0275997A1 (en) * 1987-01-20 1988-07-27 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, process for its preparation and antagonistic agent against SRS-A containing it
EP0376079A1 (en) * 1988-12-20 1990-07-04 Nissan Chemical Industries Ltd. 3(2H)pyridazinones, processes for their preparation and antagonistic agent against SRS-A
WO1990013292A1 (en) * 1989-04-28 1990-11-15 Brigham And Women's Hospital Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
EP0482208A1 (en) * 1990-04-25 1992-04-29 Nissan Chemical Industries Ltd. Pyridazinone derivative

Also Published As

Publication number Publication date
US5763439A (en) 1998-06-09
TW259787B (cg-RX-API-DMAC10.html) 1995-10-11
DE69414716T2 (de) 1999-04-08
AU681694B2 (en) 1997-09-04
ATE173471T1 (de) 1998-12-15
DE69414716D1 (de) 1998-12-24
IL110845A0 (en) 1994-11-28
AU7467694A (en) 1995-03-27
EP0717734A1 (en) 1996-06-26
EP0717734B1 (en) 1998-11-18
WO1995007264A1 (en) 1995-03-16
CA2170637C (en) 2005-01-25
IL110845A (en) 1999-01-26
CA2170637A1 (en) 1995-03-16
ES2125474T3 (es) 1999-03-01
CN1130378A (zh) 1996-09-04
KR960704853A (ko) 1996-10-09

Similar Documents

Publication Publication Date Title
AU2012312305B2 (en) Acyclic cyanoethylpyrazoles as janus kinase inhibitors
CN1048245C (zh) 5-吡咯基-2-吡啶基甲基亚磺酰基苯并咪唑衍生物,其制备方法及含它们的抗溃疡组合物
EP2842955B1 (en) Trk-inhibiting compound
CN112566900B (zh) 免疫调节剂及其组合物和制备方法
JP2019052181A (ja) Ezh2阻害のための塩酸塩形
JP6358639B2 (ja) 6員複素環誘導体およびそれらを含有する医薬組成物
WO2016041489A1 (zh) 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法
WO1998022459A1 (fr) Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
JPH05506455A (ja) ロイコトリエンd↓4拮抗剤としてのキノリニル―ベンゾヘテロ二環式誘導体
JP3741120B2 (ja) N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法
CN1802154A (zh) 吡啶n-氧化物抗病毒药
JPWO2016031987A1 (ja) オートタキシン阻害活性を有するピリミジノン誘導体
CN101796039A (zh) 苯乙酸化合物
CN1411456A (zh) 结合趋化因子受体的杂环化合物
CN1056369C (zh) 哒嗪酮衍生物或其盐和制备方法
CN101506167A (zh) 病毒聚合酶抑制剂
CN1942437A (zh) 作为环氧化酶-1-环氧化酶-2抑制剂的取代氮杂环丁烷化合物及其制备方法和作为药物的用途
WO2006051826A1 (ja) 含窒素複素環化合物およびその医薬用途
WO2022007772A1 (zh) 取代苯并咪唑类衍生物及其应用
CN1649843A (zh) 新查耳酮衍生物及其应用
CN1244573C (zh) 苯并吡喃类化合物、其制备方法和用途
CN115667190B (zh) 双环类化合物及其应用
CN1379776A (zh) 包含噻唑烷二酮衍生物的药物组合物及其制备方法
CN1196697C (zh) 噻吩-乙基硫脲化合物及其在治疗hiv中的应用
CN1128996A (zh) 取代的芳硫基烷硫基吡啶

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee